![Russell Clayton](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Förmögenhet: 248 622 $ per 2026-05-31
Russell G.
Clayton is currently Chief Medical Officer at Larimar Therapeutics, Inc. since 2023.
Former positions include Regional Medical Director-Scientific Affairs at Merck & Co., Inc., Director-Asthma Program Division at The Children's Hospital of Philadelphia Foundation, Chief Medical Officer at Alcresta Therapeutics, Inc. from 2015 to 2017, and Senior Vice President-Research & Development at Windtree Therapeutics, Inc. from 2011 to 2014.
Education includes undergraduate studies at LaSalle University and a doctorate from Philadelphia College of Osteopathic Medicine.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-01-26 | 71 443 ( 0,08 % ) | 248 622 $ | 2026-05-31 |
| Företag | Position | Start |
|---|---|---|
| LARIMAR THERAPEUTICS, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2023-07-17 |
| Företag | Position | Slut |
|---|---|---|
Alcresta Therapeutics, Inc.
 Alcresta Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Develops enzyme-based products that deliver enzymatic solutions to those living with rare diseases | Teknisk/Vetenskaplig/F&U Direktör | 2017-04-01 |
| WINDTREE THERAPEUTICS, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2014-11-01 |
The Children's Hospital of Philadelphia Foundation
 The Children's Hospital of Philadelphia Foundation Hospital/Nursing ManagementHealth Services Provides health care services | Företagsledare/Principal | - |
| MERCK & CO., INC. | Teknisk/Vetenskaplig/F&U Direktör | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 7 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Windtree Therapeutics, Inc.
 Windtree Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel therapeutics to address significant unmet medical needs in acute care markets | Health Technology |
LaSalle University
 LaSalle University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Children's Hospital of Philadelphia Foundation
The Children's Hospital of Philadelphia Foundation Hospital/Nursing ManagementHealth Services Provides health care services | Health Services |
Philadelphia College of Osteopathic Medicine
 Philadelphia College of Osteopathic Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alcresta Therapeutics, Inc.
Alcresta Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Develops enzyme-based products that deliver enzymatic solutions to those living with rare diseases | Health Technology |
Larimar Therapeutics, Inc.
 Larimar Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company focused on developing treatments for complex rare diseases | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån
